MedTrace Logo

Testing the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia

NCT06979778 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-05-23

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if using the "See Yourself Differently" (syd) app can help improve quality of life and mental health for university students in Saudi Arabia. The study also aims to see if the app can help lower anxiety and stress, and increase positive feelings while decreasing negative feelings.

The main questions it aims to answer are:

1. Does the "syd" app improve the quality of life for university students?
2. Does the "syd" app help lower anxiety and stress in university students
3. Does the "syd" app help increase positive feelings and decrease negative feelings in university students?

Researchers will compare students who use the "syd" app to see if it works.

Participants will:

1. Use the "syd" app for 3 months.
2. Complete surveys about their quality of life, anxiety, stress, and feelings.

Conditions

  • Quality of Life (QOL)
  • Anxiety
  • Stress
  • Affect (Mental Function)

Interventions

DEVICE

See Yourself Differently (syd) mobile app

The 'syd' mobile app is designed as an AI-powered "Life Quality Mentor" with the primary aim of enhancing users' quality of life. The app focuses on positive habit development, personalised feedback, and continuous support. It offers personalised guidance across various domains, including Physical health, Emotional health, Brain power, Self-awareness, Purpose, Career, Financial health, Social life and Environment. It utilizes an advanced AI platform and offers features like personalised recommendations, supportive interaction with an AI mentor, habit tracking tools, and integration with wearable technology.

Sponsors & Collaborators

  • Alfaisal University

    collaborator UNKNOWN

  • iamYiam Limited

    lead INDUSTRY

Principal Investigators

  • Ahmed Abu-Zaid, MD · Alfaisal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979778 on ClinicalTrials.gov